陷入复杂性:一个数字诱导的跌倒,创伤,症状勃拉迪卡迪和昏迷的案例
Rajathadri H Ravikumar1, Baby Pegu1, Himanti Bansal1
1Department of Anaesthesiology, Pain Medicine and Critical Care, All India Institute of Medical Sciences, New Delhi, Delhi, India.
这份案例报告强调了慢性病的老年男性的迪戈辛毒性. 未调整的狄戈辛剂量导致毒性,导致昏睡和心脏阻塞,强调在风险患者中进行仔细监测.
科学领域:
- 心脏病学 心脏病学
- 临床药理学 临床药理学
背景情况:
- 迪戈辛是一种心脏糖化物,抑制了Na+/K+-ATPase.
- 迪戈辛具有狭窄的治疗范围,使血清水平容易变化.
- 慢性狄戈辛毒性可以表现为各种心律失常,包括心脏阻塞和心室低心率.
研究的目的:
- 在老年男性中呈现狄戈辛毒性病例.
- 为了说明与狄戈辛毒性相关的临床表现和风险因素.
- 为了强调剂量调整在功能受损的患者的重要性.
主要方法:
- 一个老年男性患者的病例报告.
- 审查患者的病史,包括慢性病.
- 分析心电图 (ECG) 发现和胆毒素血清水平 (隐含).
主要成果:
- 患者出现了昏迷和轻度创伤性脑损伤.
- 最初的心电图表明心肌梗塞,演变为胸肌梗塞和完全的心脏阻塞.
- 这种毒性归因于慢性脏疾病的背景下每天0.25mg的迪戈辛剂量未经调整.
结论:
- 这一案例说明了狄戈辛毒性的经典表现.
- 高龄,功能受损和缺乏剂量调整是显著的危险因素.
- 在患有功能障碍的患者中,持续的狄戈辛治疗需要谨慎监测和适当的剂量修改.
更多相关视频
08:28Methods for ECG Evaluation of Indicators of Cardiac Risk, and Susceptibility to Aconitine-induced Arrhythmias in Rats Following Status Epilepticus
Published on: April 5, 2011
14:09Tilt Testing with Combined Lower Body Negative Pressure: a "Gold Standard" for Measuring Orthostatic Tolerance
Published on: March 21, 2013
相关概念视频
Decreased pulse rate
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...
Heart Failure Drugs: Inotropic Agents
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
Heart Failure Drugs: β-Blockers
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
ECG Interpretation of Arrhythmias I: Sinus Arrhythmias
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...
